These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7318159)

  • 1. Effect of neonatal castration on liver tumor induction by N-2-fluorenylacetamide in suckling BALB/c mice.
    Toh YC
    Carcinogenesis; 1981; 2(11):1219-21. PubMed ID: 7318159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
    Katayama S; Ohmori T; Maeura Y; Croci T; Williams GM
    J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent responses to 2-acetylaminofluorene in BALB/c female mice.
    Greenman DL; Boothe A; Kodell R
    J Toxicol Environ Health; 1987; 22(2):113-29. PubMed ID: 3669095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.
    Merritt WD; Richardson CL; Keenan TW; Morré DJ
    J Natl Cancer Inst; 1978 Jun; 60(6):1313-27. PubMed ID: 206706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously.
    Farmer JH; Kodell RL; Greenman DL; Shaw GW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):55-68. PubMed ID: 7365386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of life-shortening effects in female BALB/C mice fed 2-acetylaminofluorene.
    Kodell RL; Farmer JH; Littlefield NA; Frith CH
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):69-87. PubMed ID: 7365387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between DNA adduct formation and tumorigenesis in livers and bladders of mice chronically fed 2-acetylaminofluorene.
    Poirier MC; Fullerton NF; Kinouchi T; Smith BA; Beland FA
    Carcinogenesis; 1991 May; 12(5):895-900. PubMed ID: 2029755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of hypothalamic lesions on liver tumor induction by N-2-fluorenylacetamide in male rats.
    Toh YC
    Cancer Res; 1978 Jan; 38(1):42-51. PubMed ID: 201376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic and morphologic characteristics of hepatocellular lesions in BALB/c female mice fed 2-acetylaminofluorene.
    Frith CH; Kodell RL; Littlefield NA
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):121-38. PubMed ID: 7365376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between spontaneous and experimentally induced tumors in female BALB/c mice in a large 2-acetylaminofluorene study.
    Shinohara Y; Frith CH
    J Environ Pathol Toxicol Oncol; 1986; 6(5-6):85-95. PubMed ID: 3783444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phenacetin and N-alkylacetanilides on N-2-fluorenylacetamide hepatocarcinogenesis.
    Yamamoto RS; Frankel HH; Weisburger EK
    Cancer Lett; 1979 Dec; 8(2):183-8. PubMed ID: 555875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of distributions of time to appearance of tumor and time to death from tumor after appearance in mice fed 2-acetylaminofluorene.
    Kodell RL; Farmer JH; Greenman DL; Frith CH
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):89-102. PubMed ID: 7365388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression in primary liver and colon tumor induction with N-hydroxy-N-2-fluorenylacetamide and azoxymethane.
    Kroes R; Berkvens JM; Weisburger JH
    Cancer Res; 1975 Oct; 35(10):2651-6. PubMed ID: 1171724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thresholds of carcinogenicity in the ED01 study.
    Andersen ME; Conolly RB; Gaylor DW
    Toxicol Sci; 2003 Aug; 74(2):486-7; author reply 487-8. PubMed ID: 12874369
    [No Abstract]   [Full Text] [Related]  

  • 15. The ED01 study: summary and conclusions.
    Gaylor DW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):179-83. PubMed ID: 7365380
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study.
    Crump KS; Clewell HJ
    Toxicol Sci; 2003 Aug; 74(2):485; author reply 485-6. PubMed ID: 12730607
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of alpha-benzene hexachloride on 2-fluorenylacetamide carcinogenesis in rats.
    Hiasa Y; Ohshima M; Ohmori T; Murata Y
    Gan; 1978 Jun; 69(3):423-6. PubMed ID: 78868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular ligandin during N-2-fluorenylacetamide carcinogenesis.
    Bhargava MM; Ohmi N; Arias IM; Becker FF
    Oncology; 1982; 39(6):378-81. PubMed ID: 7133603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of agreement among findings of pathologists in ED01 experiment.
    Amato DA; Lagakos SW
    J Natl Cancer Inst; 1988 Aug; 80(12):919-25. PubMed ID: 3398066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neonatal and adult castration and of testosterone substitution in male rats on growth of enzyme-altered hepatic foci in the resistant hepatocyte model.
    Lindhe B; Porsch-Hällström I; Gustafsson JA; Blanck A
    Cancer Res; 1990 May; 50(9):2679-82. PubMed ID: 2328493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.